Engagement — Platform Due Diligence
Code & Co. provides Tech & Product Due Diligence to VIA equity ahead of its investment in DMRZ, a leading German provider of cloud-based billing software in the healthcare sector.
The shareholders of Deutsches Medizinrechenzentrum GmbH (“DMRZ”) have chosen to strengthen its growth path by bringing VIA equity on board as the new majority shareholder. As part of the transaction the current management and founders, Thomas Gazda, René Gelin and Georg Mackenbrock, will reinvest alongside VIA equity.
Scope of Work
Code & Co. conducted a comprehensive audit of DMRZ’s billing software. This included an analysis of DMRZ’s software architecture, infrastructure, deployment capabilities, technology stack, and artificial intelligence/machine learning capabilities. Additionally, Code & Co. analyzed DMRZ’s product roadmap, integration and rollout capabilities, and support procedures. Lastly, DMRZ’s underlying engineering team, software development lifecycle, and quality assurance processes were examined.
About DMRZ
Headquartered in Dusseldorf, Germany, DMRZ is a German provider of cloud-based DIY billing software for medical prescription validation and statutory health insurances billing for other care providers. Operating in a complex and regulated market, DMRZ focuses on data protection, AI-supported automation, and customer satisfaction. The company employs more than 50 people at its offices in Düsseldorf and Vienna. For further information, please visit https://www.dmrz.de.
About VIA equity
VIA equity is a leading Northern European private equity firm with an excellent track record of developing and transforming its portfolio companies into national and international industry leaders. The core investment focus of VIA equity is within a broad definition of software and IT-service business models. With offices in Denmark and Germany, VIA equity manages five funds, where the most recent one alone has EUR 250m in committed capital from established international investors. For further information, please visit www.viaequity.com.